Global Therapeutic BCG Vaccines Market Report 2024

Therapeutic BCG Vaccines Global Market Report 2024 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Therapeutic BCG Vaccines Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Therapeutic Bcg Vaccines Market Definition And Segments

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.

The two major types of therapeutic BCG vaccines are therapy BCG and immune BCG. Therapy BCG refers to a kind of intravesical immunotherapy that aids the immune system's destruction of cancer cells and is frequently used to treat bladder cancer in its early stages. By demographics, BCG vaccines can be used on pediatrics and adults. These are used by several end-users, such as hospitals, clinics, and other end-users.

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

The therapeutic bcg vaccines market size has grown strongly in recent years. It will grow from $53.99 billion in 2023 to $57.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains.

The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to $72.54 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches.

Fighting Tuberculosis Surging Global Cases Propel Growth In The Therapeutic Bcg Vaccine Market

The rising number of tuberculosis (TB) cases worldwide will propel the growth of the therapeutic BCG vaccine market going forward. Tuberculosis (TB) is an infectious illness that can be potentially dangerous and primarily impacts the lungs. People can contract tuberculosis from one another by coughing or sneezing small droplets of bacteria into the air. BCG vaccines are used to stimulate the immune system to fight infection but do not cause TB since the germs are weak. It consistently offers protection against the most dangerous types of TB, such as adolescent TB meningitis. The BCG vaccine protects against tuberculosis which helps to fight against infection, hence the usage of therapeutic BCG vaccines increased. For instance, in October 2022, according to a report published by the World Health Organization, a specialized agency of the United Nations responsible for international public health, 10.6 million people were predicted to have contracted tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million died from TB (including 187,000 HIV-positive individuals). Therefore, the rising number of tuberculosis (TB) cases worldwide is driving the growth of the therapeutic BCG vaccine market.

Therapeutic Bcg Vaccines Rise To The Challenge Amidst Growing Drug-Resistant Tuberculosis Incidence

The rising incidence of drug-resistant TB cases is expected to propel the growth of the therapeutic BCG vaccine market in the coming years. Drug-resistant tuberculosis (TB) is a kind of tuberculosis in which the bacteria responsible for the disease, Mycobacterium tuberculosis, acquire resistance to the medications routinely used to treat the infection. Therapeutic Bacillus Calmette-Guérin (BCG) vaccines, while primarily known for their use in preventing certain forms of tuberculosis (TB), have also been explored in the context of drug-resistant tuberculosis (DR-TB). For instance, in November 2023, according to the Centers for Disease Control and Prevention, a US-based federal agency that works for the Department of Health and Human Services, resistance to at least isoniazid was recorded in 528 (8.4%) of TB cases in the United States in 2022, including 90 (1.4%) multidrug resistance cases. Among those born in the United States, 86 (5.7%) had INH-resistant TB, with 11 (0.7%) having MDR TB. Therefore, the rising incidence of drug-resistant TB cases is driving the therapeutic BCG vaccine market.

Major companies operating in the therapeutic bcg vaccines market report are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd., Biomed Lublin S.A., PowderJect Pharmaceuticals, Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., GlaxoSmithKline PLC, Pfizer Inc., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Immunitor, Vakzine Projekt Management GmbH, Cipla Limited, Instituto Butantan, Chiron Corporation .

Zendal And Us-Based Nonprofit Forge Strategic Partnership To Advance Therapeutic Bcg Vaccine Development

Strategic partnerships have emerged as a key trend gaining popularity in the therapeutic BCG vaccine market. Major companies operating in the therapeutic BCG vaccine market are focused on collaborating with other key players to sustain their position in the market. For instance, in July 2021, Zendal, a Spain-based pharmaceutical company, partnered with IAVI, a US-based not-for-profit organization to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. The only live, attenuated Mycobacterium tuberculosis vaccine currently being developed is MTBVAC. It is now being developed to prevent tuberculosis in adults and adolescents, for whom there is currently no effective vaccination, and as a more potent and potentially long-lasting vaccine than BCG for infants. This statement coincides with the rapid development of several vaccinations to guard against COVID-19.

Innovative Therapeutic Applications Of Bcg Immunotherapy

Major companies operating in the therapeutic BCG vaccine market are focused on innovating vaccines for potential therapeutic applications in various medical conditions, such as BCG immunotherapy, to expand their customer base and meet growing patient needs. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the use of the BCG vaccine as a form of immunotherapy to treat certain types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, received government approval to export its BCG vaccine to Canada for immunotherapeutic use in treating bladder cancer. This live freeze-dried preparation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is intended for intravenous instillation. The vaccine is available in 40 mg and 80 mg presentations. As an integral part of the therapy, the vaccine is administered directly into the bladder through a catheter, where it remains in the bladder lining for a specified duration. This targeted approach aims to impact cancer cells effectively while minimizing impact on other parts of the body.

Sanofi Enhances Oncology Therapeutics Portfolio With Acquisition Of Amunix And Innovative Pro-Xten Technology

In February 2022, Sanofi S.A., a France-based multinational pharmaceutical and healthcare company, acquired Amunix for an undisclosed amount. This acquisition provides access to Amunix Pro-XTEN, XPAT, and XPAC technology to deliver conditionally activated biologics of the next generation. The technology platform supports Sanofi's efforts to accelerate and expand its contributions to cutting-edge therapies for oncology patients, with about 20 compounds presently in development. It is a perfect addition to Sanofi's existing R&D platforms. Amunix is a US-based immuno-oncology company intended to discover, design, and develop novel biologics, proteins, and peptide therapeutics.

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2023. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the therapeutic bcg vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic BCG vaccines market consists of sales of vectors, peptides, proteins, DNA, and dendritic cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The therapeutic BCG vaccines market research report is one of a series of new reports from The Business Research Company that provides therapeutic BCG vaccines market statistics, including therapeutic BCG vaccines industry global market size, regional shares, competitors with a therapeutic BCG vaccines market share, detailed therapeutic BCG vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic BCG vaccines industry. This therapeutic BCG vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Therapeutic BCG Vaccines Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $57.14 billion
Revenue Forecast In 2033 $72.54 billion
Growth Rate CAGR of 6.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Merck & Co Inc.; Sanofi Pasteur; Japan BCG Laboratory; China National Biotec Group; Serum Institute of India Pvt. Ltd.; InterVax Ltd.; GreenSignal Bio Pharma Limited; Statens Serum Institute; AJ Vaccines; Bul Bio-National Center of Infectious and Parasitic Diseases Ltd; Biomed Lublin S.A.; PowderJect Pharmaceuticals; Microgen; Taj Pharma Ltd.; PT Bio Farma; Torlak Institute of Virology; Bacille Bilie Calmette-Guerin Laboratory; China Biotechnology Co Ltd.; GlaxoSmithKline plc; Pfizer Inc.; Bharat Biotech International Ltd.; Biological E. Limited; Shanghai Institute of Biological Products Co. Ltd.; Immunitor; Vakzine Projekt Management GmbH; Cipla Limited; Instituto Butantan; Chiron Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Therapeutic BCG Vaccines Market Characteristics

    3. Therapeutic BCG Vaccines Market Trends And Strategies

    4. Therapeutic BCG Vaccines Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Therapeutic BCG Vaccines Market Size and Growth

    5.1. Global Therapeutic BCG Vaccines Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Therapeutic BCG Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Therapeutic BCG Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Therapeutic BCG Vaccines Market Segmentation

    6.1. Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Therapy BCG

    Immune BCG

    6.2. Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pediatrics

    Adults

    6.3. Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Clinics

    Other End Users  

    7. Therapeutic BCG Vaccines Market Regional And Country Analysis

    7.1. Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Therapeutic BCG Vaccines Market  

    8.1. Asia-Pacific Therapeutic BCG Vaccines Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Therapeutic BCG Vaccines Market  

    9.1. China Therapeutic BCG Vaccines Market Overview  

    9.2. China Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Therapeutic BCG Vaccines Market  

    10.1. India Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Therapeutic BCG Vaccines Market  

    11.1. Japan Therapeutic BCG Vaccines Market Overview  

    11.2. Japan Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Therapeutic BCG Vaccines Market  

    12.1. Australia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Therapeutic BCG Vaccines Market  

    13.1. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Therapeutic BCG Vaccines Market  

    14.1. South Korea Therapeutic BCG Vaccines Market Overview  

    14.2. South Korea Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Therapeutic BCG Vaccines Market  

    15.1. Western Europe Therapeutic BCG Vaccines Market Overview

    15.2. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Therapeutic BCG Vaccines Market  

    16.1. UK Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Therapeutic BCG Vaccines Market  

    17.1. Germany Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Therapeutic BCG Vaccines Market  

    18.5. France Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Therapeutic BCG Vaccines Market  

    19.9. Italy Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Therapeutic BCG Vaccines Market  

    20.13. Spain Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Therapeutic BCG Vaccines Market  

    21.1. Eastern Europe Therapeutic BCG Vaccines Market Overview

    21.2. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Therapeutic BCG Vaccines Market  

    22.1. Russia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Therapeutic BCG Vaccines Market  

    23.1. North America Therapeutic BCG Vaccines Market Overview

    23.2. North America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Therapeutic BCG Vaccines Market  

    24.1. USA Therapeutic BCG Vaccines Market Overview

    24.2. USA Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Therapeutic BCG Vaccines Market  

    25.1. Canada Therapeutic BCG Vaccines Market Overview

    25.2. Canada Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Therapeutic BCG Vaccines Market  

    26.1. South America Therapeutic BCG Vaccines Market Overview

    26.2. South America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Therapeutic BCG Vaccines Market  

    27.1. Brazil Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Therapeutic BCG Vaccines Market  

    28.1. Middle East Therapeutic BCG Vaccines Market Overview

    28.2. Middle East Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Therapeutic BCG Vaccines Market  

    29.1. Africa Therapeutic BCG Vaccines Market Overview

    29.2. Africa Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Therapeutic BCG Vaccines Market Competitive Landscape And Company Profiles

    30.1. Therapeutic BCG Vaccines Market Competitive Landscape

    30.2. Therapeutic BCG Vaccines Market Company Profiles

    30.2.1. Merck & Co Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Sanofi Pasteur

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Japan BCG Laboratory

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. China National Biotec Group

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Serum Institute of India Pvt. Ltd.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Therapeutic BCG Vaccines Market Competitive Benchmarking

    32. Global Therapeutic BCG Vaccines Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Therapeutic BCG Vaccines Market

    34. Therapeutic BCG Vaccines Market Future Outlook and Potential Analysis

    34.1 Therapeutic BCG Vaccines Market In 2028 - Countries Offering Most New Opportunities

    34.2 Therapeutic BCG Vaccines Market In 2028 - Segments Offering Most New Opportunities

    34.3 Therapeutic BCG Vaccines Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Merck & Co Inc. Financial Performance
  • Table 75: Sanofi Pasteur Financial Performance
  • Table 76: Japan BCG Laboratory Financial Performance
  • Table 77: China National Biotec Group Financial Performance
  • Table 78: Serum Institute of India Pvt. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Merck & Co Inc. Financial Performance
  • Figure 75: Sanofi Pasteur Financial Performance
  • Figure 76: Japan BCG Laboratory Financial Performance
  • Figure 77: China National Biotec Group Financial Performance
  • Figure 78: Serum Institute of India Pvt. Ltd. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Wound Care Devices Global Market Report 2024 – By Type (Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types), By End-User (Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pain Management Devices And Therapies Global Market Report 2024 – By Type (Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps), By Neurostimulation Devices (Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices), By Electrical Stimulation Devices (Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS), By Ablation Devices (Radiofrequency Ablation Devices, Cryoablation Devices), By Analgesic Infusion Pumps (Intrathecal Infusion Pumps, External Infusion Pumps), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Defibrillator Devices And Equipment Global Market Report 2024 – By Type (Implantable Defibrillators, External defibrillators), By Implantable Defibrillators (Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D), Single & Dual Chamber), By External defibrillators (Manual External Defibrillator (MEDs), Automated External Defibrillator (AEDs), Wearable Cardioverter Defibrillator (WCDs)), By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home Healthcare) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024 – By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), By Application (Bradycardia, Tachycardia, Heart Failure, Other Applications), By End User (Hospitals, Ambulatory surgical centers, Physicians Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Orthobiologics Devices And Equipment Global Market Report 2024 – By Product Type (Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics), By Application (Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery), By End Use (Hospitals, Orthopedic Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Transdermal Skin Patches Global Market Report 2024 – By Product (Matrix, Drug In Adhesive, Reservoir, Vapor), By Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types), By Distribution Channel (Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Convalescent Plasma Therapy Global Market Report 2024 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the therapeutic BCG vaccines market?

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime. For further insights on the therapeutic BCG vaccines market, request a sample here

How will the therapeutic BCG vaccines market drivers and restraints affect the therapeutic BCG vaccines market dynamics? What forces will shape the therapeutic BCG vaccines industry going forward?

The therapeutic BCG vaccines market major growth driver - fighting tuberculosis surging global cases propel growth in the therapeutic bcg vaccine market. For further insights on the therapeutic BCG vaccines market, request a sample here

What is the forecast market size or the forecast market value of the therapeutic BCG vaccines market ?

The therapeutic BCG vaccines market size has grown strongly in recent years. It will grow from $53.99 billion in 2023 to $57.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains.. The therapeutic BCG vaccines market size is expected to see strong growth in the next few years. It will grow to $72.54 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination.. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches.. For further insights on the therapeutic BCG vaccines market, request a sample here

How is the therapeutic BCG vaccines market segmented?

The therapeutic BCG vaccines market is segmented
1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users For further insights on the therapeutic BCG vaccines market, request a sample here

Which region has the largest share of the therapeutic BCG vaccines market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2023. The regions covered in the therapeutic BCG vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the therapeutic BCG vaccines market, request a sample here.

Who are the major players in the therapeutic BCG vaccines market?

Major companies operating in the therapeutic BCG vaccines market report are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., PowderJect Pharmaceuticals, Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., GlaxoSmithKline plc, Pfizer Inc., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Immunitor, Vakzine Projekt Management GmbH, Cipla Limited, Instituto Butantan, Chiron Corporation . For further insights on the therapeutic BCG vaccines market, request a sample here.

What are the key trends in the therapeutic BCG vaccines market?

Major trend in the therapeutic BCG vaccines market - zendal and us-based nonprofit forge strategic partnership to advance therapeutic bcg vaccine development. For further insights on the therapeutic BCG vaccines market, request a sample here.

What are the major opportunities in the therapeutic BCG vaccines market? What are the strategies for the therapeutic BCG vaccines market?

For detailed insights on the major opportunities and strategies in the therapeutic BCG vaccines market, request a sample here.

How does the therapeutic BCG vaccines market relate to the overall economy and other similar markets?

For detailed insights on therapeutic BCG vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the therapeutic BCG vaccines industry?

For detailed insights on the mergers and acquisitions in the therapeutic BCG vaccines industry, request a sample here.

What are the key dynamics influencing the therapeutic BCG vaccines market growth? SWOT analysis of the therapeutic BCG vaccines market.

For detailed insights on the key dynamics influencing the therapeutic BCG vaccines market growth and SWOT analysis of the therapeutic BCG vaccines industry, request a sample here.